NJ-ACS Mass Spec Discussion Group
The NJ Mass Spectrometry Discussion Group is pleased to announce our May Monthly Meeting.
NJ MSDG is the second largest mass spectrometry professional association in the nation behind ASMS, with over 1,100 members in the tristate area. [ homepage ]

Date:    Wednesday May 10, 2017

Venue:   Holiday Inn Somerset-Bridgewater
        195 Davidson Avenue, Somerset, NJ 08873

Sponsor: Bruker Daltonics

Bruker Datonics, Inc

Please  register here.  Registration is free, compliments to our sponsor.


5:30 PM    Social and Registration  
6:15 PM    Complimentary Dinner
7:00 PM    Welcome and Opening Remarks
7:05 PM    Speakers

Speaker 1:  Tao He, PhD

Associate Research Fellow, BioMedicine Design, Pfizer Inc

“Impact of Ultra-High Resolution Mass Spectrometry on Early Stage Developability Assessment”

Abstract for Dr He:

Early analytical profiling has become an integral component in biologics discovery & development. This presentation will highlight the impact of applying ultra-high resolution mass spectrometry to facilitate selection and engineering of biologics leads. Approaches to minimize risks associated with chemical degradation and other biophysical properties will be discussed.

Speaker 2:  Jason Wood, Ph.D.

Market Area Manager – BioPharma, Bruker Daltonics

“Overcoming the Challenges of Intact Biotherapeutics Characterization with Ultra-High Resolution Mass Spectrometers and the Latest in Automated Biopharmaceutical Software Package – Biopharma Compass 2.0”

Abstract for Dr Wood:

Attendees of this technology seminar will hear about the latest advancements in ultrahigh-resolution time-of-flight hardware and their application to the analytical challenges facing innovators and biosimilars characterization labs.  Innovations in hardware, software and application-specific workflows will be highlighted.  In particular, the use of MALDI- and LC-TOF hardware in combination, all acquired and visualized with a single, ease-to-use, 21CFR Part 11 compliant software package; Biopharma Compass 2.0. Several case studies involving monoclonal antibodies characterization will be presented to highlight: How high-confidence (high resolution) intact/subunit workflows improves labs productivity and; how automation of routine data processing tasks improves the system utilization time.